| CL3227A |
|
2119669-71-3 |
Asciminib hydrochloride
Asciminib hydrochloride (Synonyms: ABL001 hydrochloride)
-
98+%
|
需询价 |
C20H19Cl2F2N5O3 |
|
|
|
| CL3227 |
|
1492952-76-7 |
Asciminib
Asciminib (Synonyms: ABL001)
-
98+%
|
需询价 |
C20H18ClF2N5O3 |
|
|
|
| CL2536 |
|
1020172-07-9 |
Rebastinib (DCC-2036)
Rebastinib (DCC-2036)
3-5days
98+%
|
￥620.00 |
C30H28FN7O3 |
|
|
|
| CL2492A |
|
1421783-64-3 |
耐克替尼甲磺酸盐 | 奥雷巴替尼
Olverembatinib dimesylate (GZD824 dimesylate; HQP1351 dimesylate)
3-5days
98+%
|
￥700.00 |
C31H35F3N6O7S2 |
|
|
|
| CL2492 |
|
1257628-77-5 |
4-甲基-N-[4-[(4-甲基-1-哌嗪基)甲基]-3-(三氟甲基)苯基]-3-[2-(1H-吡唑并[3,4-b]吡啶-5-基)乙炔基]苯甲酰胺 | 耐克替尼 | 奥雷巴替尼
Olverembatinib (GZD824; HQP1351)
3-5days
98+%
|
￥650.00 |
C29H27F3N6O |
|
|
|
| CL2375A |
|
923288-90-8 |
尼洛替尼盐酸盐一水合物 | 尼罗替尼盐酸盐一水合物
Nilotinib Hydrochloride Monohydrate;Nilotinib HCl Monohydrate
In-stock
98+%
|
￥450.00 |
C28H25ClF3N7O2 |
|
|
|
| CL2375 |
|
641571-10-0 |
尼洛替尼 | 尼罗替尼 | 尼罗替尼碱
Nilotinib (AMN107)
In-stock
98+%
|
￥388.00 |
C28H22F3N7O |
|
|
|
| CL2363 |
|
943319-70-8 |
普纳替尼 | 帕纳替尼 | 泊那替尼
Ponatinib | AP24534
In-stock
98+%
|
￥236.00 |
C29H27F3N6O |
|
|
|
| CL2147 |
|
302962-49-8 |
N-(2-氯-6-甲基苯基)-2-((6-(4-(2-羟乙基)哌嗪-1-基)-2-甲基嘧啶-4-基)氨基)噻唑-5-甲酰胺; 达沙替尼
Dasatinib (Synonyms: BMS-354825)
In-stock
Purity: 99.16%
|
￥300.00 |
C22H26ClN7O2S |
|
|
|
| CL2146 |
|
220127-57-1 |
N-(4-甲基-3-((4-(吡啶-3-基)嘧啶-2-基)氨基)苯基)-4-((4-甲基哌嗪-1-基)甲基)苯甲酰胺甲磺酸盐
Imatinib Mesylate (Synonyms: STI571 Mesylate; CGP-57148B Mesylate; 甲磺酸伊马替尼)
In-stock
98+%
|
￥366.00 |
C30H35N7O4S |
|
|
|
